Concepedia

Author

Yulia Benitex

Bristol-Myers Squibb (United States)

Also Known As

Benitex, Yulia, Yulia Benitex

24

Publications

436

Citations

12

H-Index

49

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University of Illinois Urbana-ChampaignWesleyan University
YB

About

Yulia Benitex is an author at Bristol-Myers Squibb (United States) specializing in neuropharmacology, neuroscience, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

205

2

Social Sciences

4

4

76

3

Cognitive Science

3

3

63

4

Engineering

1

1

41

5

Health Sciences

1

1

129

Yulia Benitex

×

12

Publications

393

Citations

12

H-Index

YearCitations

40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors

Digavalli V. Sivarao, Ping Chen, Arun Senapati,

Neuropsychopharmacology

2016

129

Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors

Andrew Alt, Annapurna Pendri, R.L. Bertekap,

Journal of Pharmacology and Experimental Therapeutics

2015

45

Affinity and Specificity of Protein U1A-RNA Complex Formation Based on an Additive Component Free Energy Model

Bethany L. Kormos, Yulia Benitex, Anne M. Baranger,

Journal of Molecular Biology

2007

41

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

Linda J. Bristow, Amy Easton, Yu-Wen Li,

PLoS ONE

2016

30

The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation

Alicia Regueiro‐Ren, Sing‐Yuen Sit, Yan Chen,

Journal of Medicinal Chemistry

2022

25

Control of the Stability of a Protein−RNA Complex by the Position of Fluorine in a Base Analogue

Yulia Benitex, Anne M. Baranger

Journal of the American Chemical Society

2011

24

Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies

Amy Easton, Marianne L. Jensen, Congwei Wang,

Molecular Therapy — Nucleic Acids

2022

23

Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents

Rick L. Pieschl, Regina Miller, Kelli Jones,

European Journal of Pharmacology

2017

21

Design and Synthesis of a New Series of 4-Heteroarylamino-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure–Activity Relationship

James A. Cook, F. Christopher Zusi, Ivar M. McDonald,

Journal of Medicinal Chemistry

2016

18

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia

Dalton King, Christiana Iwuagwu, Jim Cook,

ACS Medicinal Chemistry Letters

2017

13

Page 1